Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Why the weirdest sea level changes on Earth are happening off the coast of Japan - 2The Response to Self-improvement: Embracing a Development Outlook
- 3Sentimental tree to shine at Arctic League annual broadcast
- 4A Couple of Reasonable Guitars for 2024
- 5Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder
- New movies to watch this weekend: See 'We Bury the Dead' in theaters, rent 'Wicked: For Good,' stream 'The Unbreakable Boy' on Starz
- Lucrative Positions in the Advancing Position Market of 2024
- Flu season is underway. What are common symptoms to watch for?
- The Best Portable Applications for Emotional wellness and Prosperity
- Santa's sleigh or the International Space Station? How to spot a bright Christmas flyby Dec. 24 and 25
- Antimatter took to the road for the very first time. Here’s why it matters
- Merz: 80% of Syrians in Germany should return in three years
- There’s ‘super flu,’ COVID, RSV. Is it going around in SoCal?
- Step by step instructions to Pick the Right Web-based Degree Program
